Bjork Elisabeth
- SEC CIK
- 0001810406
Latest role at each company
- PHVS Pharvaris N.V.Directoras of Sep 21, 2026
- RCKT ROCKET PHARMACEUTICALS, INC.Directoras of Jan 6, 2026
Trades
Every Form 4 that lists Bjork Elisabeth as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | Sep 21, 20263:20 PM ET | Sep 17, 2026 | Bjork ElisabethDirector | SSaleCommon Stock | −52.5K | $37.8935 | −$1.99M | 15.17K | −77.6% | SEC |
| PHVSPharvaris N.V. | May 22, 2026 | May 20, 2026 | Bjork ElisabethDirector | SSaleCommon Stock | −10K | $29.32 | −$293.2K | 15.17K | −39.7% | SEC10b5-1 |
| RCKTROCKET PHARMACEUTICALS, INC. | Jan 6, 2026 | Jan 2, 2026 | Bjork ElisabethDirector | PPurchaseCommon Stock | +10K | $3.44 | +$34.4K | 50K | +25.0% | SEC |
| RCKTROCKET PHARMACEUTICALS, INC. | Aug 27, 2025 | Aug 27, 2025 | Bjork ElisabethDirector | PPurchaseCommon Stock | +10K | $3.41 | +$34.1K | 40K | +33.3% | SEC |